Development in Regenerative Science: Exosomes show promise for neurological conditions
Save the Date! Cell Surgical Conference May 31st-June 2nd, 2019
May 31st– June 2nd, Beverly Hills, CA The 6th Annual Cell Surgical Conference looks to pick up right where this past summer’s meeting left off. If you missed it, we had a full weekend of lectures, from internationally renowned speakers who have pioneered and continue to lead the way forward in the entire field of…
Personal Cell Therapy – Why Using Your Own Cells Are So Important
Why PCT? – Personal Cell Therapy Allogeneic cells represent a robust business model for tissue banks and ultimately for big pharma who will industrialize them once approved through the FDA. Tissue banks selling umbilical cord stem cells have popped up left and right selling a host of products; live cells, radiated sterile dead cells, and…
Neuroethics Canada
Pictured from Left to Right: Dr. Jonathan Brock, Dr. Elliot Lander, and Dr. Martin Braun Last week, as an outspoken bio-ethicist decried the number of “unproven stem cell clinics” popping up in Canada, Dr. Elliot Lander joined Dr. Martin Braun and Dr. Jonathan Brock of the Vancouver Stem Cell Treatment Centre for a roundtable discussion…
Call For Patient Testimonials
https://stemcellrevolution.com/patient-survey/ As you all know, we are vigorously fighting the FDA lawsuit seeking a permanent injunction to stop us from providing SVF as a point of care product to our patients. SVF is not a drug and FDA attempts to regulate our PERSONAL CELLS is a violation of our constitutional rights, a huge over-reach, inconsistent…
Update on the FDA
Nearly every time we sit down to send out an update about the legal issues with the FDA something new happens that seems to change our perspectives. First, we are not worried, upset or afraid that the FDA will prevail and end our ability to provide point of care treatments for our patients. Indeed, this…
Cells On Ice Update
2018 has been a difficult, but transformative year for Cells On Ice. In January, our banking partner American Cryostem received a warning letter from the FDA, which requested updates and changes to a number of their internal processes. The legal team for American Cryostem advised the company against releasing any patients’ stored cells prior to…